177 related articles for article (PubMed ID: 19823965)
1. An examination of the clinical benefits and cost-effectiveness of tocolytic replacement following recurrent preterm labor.
Flick AA; de la Torre L; Roca LE; Istwan N; Rhea D; Desch C; González-Quintero VH
Am J Perinatol; 2010 Jan; 27(1):53-9. PubMed ID: 19823965
[TBL] [Abstract][Full Text] [Related]
2. Management of recurrent preterm labor in twin gestations with nifedipine tocolysis.
de la Torre L; Istwan NB; Desch C; Rhea DJ; Roca L; Stanziano GJ; González-Quintero VH
Am J Perinatol; 2008 Oct; 25(9):555-60. PubMed ID: 18773381
[TBL] [Abstract][Full Text] [Related]
3. Pregnancy and economic outcomes in patients treated for recurrent preterm labor.
Fleming A; Bonebrake R; Istwan N; Rhea D; Coleman S; Stanziano G
J Perinatol; 2004 Apr; 24(4):223-7. PubMed ID: 14999214
[TBL] [Abstract][Full Text] [Related]
4. Managing perinatal outcomes: the clinical benefit and cost-effectiveness of pharmacologic treatment of recurrent preterm labor.
Lam F; Istwan NB; Jacques D; Coleman SK; Stanziano GJ
Manag Care; 2003 Jul; 12(7):39-46. PubMed ID: 12891954
[TBL] [Abstract][Full Text] [Related]
5. Clinical and cost-effectiveness of continuous subcutaneous terbutaline versus oral tocolytics for treatment of recurrent preterm labor in twin gestations.
Lam F; Bergauer NK; Jacques D; Coleman SK; Stanziano GJ
J Perinatol; 2001; 21(7):444-50. PubMed ID: 11894512
[TBL] [Abstract][Full Text] [Related]
6. The impact of acute tocolysis on neonatal outcome in women hospitalized with preterm labor at 32 to 34 weeks' gestation.
Elliott JP; Istwan NB; Rhea DJ; Desch CN; Stanziano GJ
Am J Perinatol; 2009 Feb; 26(2):123-8. PubMed ID: 18850519
[TBL] [Abstract][Full Text] [Related]
7. Nifedipine and ritodrine in the management of preterm labor: a randomized multicenter trial.
Papatsonis DN; Van Geijn HP; Adèr HJ; Lange FM; Bleker OP; Dekker GA
Obstet Gynecol; 1997 Aug; 90(2):230-4. PubMed ID: 9241299
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of oral nifedipine versus terbutaline injection in preterm labor.
Laohapojanart N; Soorapan S; Wacharaprechanont T; Ratanajamit C
J Med Assoc Thai; 2007 Nov; 90(11):2461-9. PubMed ID: 18181335
[TBL] [Abstract][Full Text] [Related]
9. Two dose regimens of nifedipine for management of preterm labor: a randomized controlled trial.
Nassar AH; Abu-Musa AA; Awwad J; Khalil A; Tabbara J; Usta IM
Am J Perinatol; 2009 Sep; 26(8):575-81. PubMed ID: 19399705
[TBL] [Abstract][Full Text] [Related]
10. A cost decision analysis of 4 tocolytic drugs.
Hayes E; Moroz L; Pizzi L; Baxter J
Am J Obstet Gynecol; 2007 Oct; 197(4):383.e1-6. PubMed ID: 17904969
[TBL] [Abstract][Full Text] [Related]
11. The association of elective cessation of tocolysis and preterm birth in singleton gestations.
Rebarber A; Cleary-Goldman J; Istwan N; Rhea D; Stanziano G; Saltzman D
Am J Perinatol; 2009 May; 26(5):351-5. PubMed ID: 19067281
[TBL] [Abstract][Full Text] [Related]
12. Clinical and economic outcomes of preterm labor management: inpatient vs outpatient.
Ambrose S; Rhea DJ; Istwan NB; Collins A; Stanziano G
J Perinatol; 2004 Aug; 24(8):515-9. PubMed ID: 15141268
[TBL] [Abstract][Full Text] [Related]
13. Magnesium sulfate compared with nifedipine for acute tocolysis of preterm labor: a randomized controlled trial.
Lyell DJ; Pullen K; Campbell L; Ching S; Druzin ML; Chitkara U; Burrs D; Caughey AB; El-Sayed YY
Obstet Gynecol; 2007 Jul; 110(1):61-7. PubMed ID: 17601897
[TBL] [Abstract][Full Text] [Related]
14. Tocolytic effectiveness of nifedipine versus ritodrine and follow-up of newborns: a randomised controlled trial.
Van De Water M; Kessel ET; De Kleine MJ; Oei SG
Acta Obstet Gynecol Scand; 2008; 87(3):340-5. PubMed ID: 18307075
[TBL] [Abstract][Full Text] [Related]
15. The interval to spontaneous delivery following discontinuation of maintenance tocolysis.
Jones JS; Morrison J; Istwan N; Rhea D; Collins A; Stanziano G
J Matern Fetal Neonatal Med; 2006 Jun; 19(6):331-5. PubMed ID: 16801308
[TBL] [Abstract][Full Text] [Related]
16. Pregnancy prolongation in triplet pregnancies. Oral vs. continuous subcutaneous terbutaline.
Elliott JP; Bergauer NK; Jacques DL; Coleman SK; Stanziano GJ
J Reprod Med; 2001 Nov; 46(11):975-82. PubMed ID: 11762154
[TBL] [Abstract][Full Text] [Related]
17. Nifedipine versus terbutaline, tocolytic effectiveness and maternal and neonatal adverse effects: a randomized, controlled pilot trial.
Padovani TR; Guyatt G; Lopes LC
Basic Clin Pharmacol Toxicol; 2015 Mar; 116(3):244-50. PubMed ID: 25146233
[TBL] [Abstract][Full Text] [Related]
18. Tocolytic treatment for preterm contractions with and without cervical changes.
Brown HL; Hiett AK; Britton KA; Turnquest MA; Golichowski AM
Am J Perinatol; 1997 Aug; 14(7):405-9. PubMed ID: 9263560
[TBL] [Abstract][Full Text] [Related]
19. The occurrence of adverse events in women receiving continuous subcutaneous terbutaline therapy.
Elliott JP; Istwan NB; Rhea D; Stanziano G
Am J Obstet Gynecol; 2004 Oct; 191(4):1277-82. PubMed ID: 15507953
[TBL] [Abstract][Full Text] [Related]
20. A placebo-controlled randomized trial of the terbutaline pump for prevention of preterm delivery.
Wenstrom KD; Weiner CP; Merrill D; Niebyl J
Am J Perinatol; 1997 Feb; 14(2):87-91. PubMed ID: 9259905
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]